Illustrating use of a clinical data system: The NMC-FMC system

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue SUPPL. 1, 2009, Pages

  Lowrie, Edmund G ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CONFERENCE PAPER; DEMOGRAPHY; DIALYSIS; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MEDICAL CARE; MEDICAL INFORMATION SYSTEM; MORTALITY; PATIENT INFORMATION; SURVIVAL;

DATA INTERPRETATION, STATISTICAL; DATABASES AS TOPIC; HUMANS; KIDNEY FAILURE, CHRONIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 73849120049     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02680409     Document Type: Conference Paper

References (42)

1. McFeeley T: Quality: Empowering the medical directors. In: The Price of Access, edited by McFeeley T, Nashua, NH, MDL Press 2001, pp 211-220
2. Hakim RM, Lowrie EG: Biochemical and hematological profiles of chronic dialysis patients. ASAIO Abstract 43. American Society for Artificial Internal Organs, Boca Raton, FL, 1981
3. McFeeley T: Adoption by WR Grace & Company.. In: The Price of Access, edited by McFeeley T, Nashua, NH, MDL Press 2001, pp 239-262
4. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kid Dis 15: 458-482, 1990
5. Deming WE: Out of Crisis, Cambridge, MA, MIT Center for Advanced Engineering Studies, 1896
6. Deming WE: The New Economics, Cambridge, MA, MIT Center for Advanced Engineering Studies, 1994
7. Berger EE, Lowrie EG: Continuous quality improvement in dialysis: Operations and controls for multi-center systems. In: Quality Assurance in Dialysis, edited by L. Henderson W, Thuma RS, Norwell, MA, Kluwer Academic Publishers, 1994, pp 47-62
8. Lowrie EG: A continuous quality improvement paradigm for health care networks. In: Quality Assurance in Dialysis, 2nd ed., edited by L. Henderson W, Thuma RS, Norwell, MA, Kluwer Academic Publishers, 1999
9. Lowrie EG, Huang WH, Lew NL, Liu Y: The relative contribution of measured variables to death risk among hemodialysis patients. In: Death on Hemodialysis: Preventable or Inevitable?, edited by Hingham MA, Friedman E, Norwell, MA, Kluwer Academic Publishers, 1994, pp 121-141
10. Lowrie EG, Lew NL: The urea reduction ratio (URR). A simple method for evaluating hemodialysis treatment. Contemp Dial Nephrol 12: 11-20, 1991
11. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
12. Hakim RM, Depner TA, Parker TF: Adequacy of dialysis. Am J Kidney Dis 20: 107-123, 1992
13. Parker TF, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kid Dis 23: 670-680, 1994
14. Lowrie EG, Zhu X, Lew NL: Primary associates of mortality among dialysis patients: Trends and reassessment of Kt/V and the urea reduction ratio as outcome-based measures of dialysis dose. Am J Kidney Dis 32[Suppl 4]: S16-S31, 1998
15. Lacson E, Teng M, Lazarus JM, Lew N Lowrie EG, Owen WF: Limitations of the facility-specific standardized mortality ratio for profiling health quality in dialysis. Am J Kidney Dis 37: 267-275, 2001
16. Lowrie EG, Teng M, Lacson E, Lew N, Lazarus JM, Owen WF: Association between prevalent process measures and facility-specific mortality rates. Kidney Int 60: 1917-1929, 2001
17. Lowrie EG, Teng M, Lew NL, Lacson EJ, Lazarus JM, Owen WF: Toward a continuous quality improvement program for hemodialysis providers with preliminary suggestions for clinical practice monitoring and measurement. Hemodial Int 7: 28-51, 2003
18. Gotch FA, Panlilio FM, Buyaki RA, Wang EX, Folden TI, Levin NW: Mechanisms determining the ratio of conductivity clearance to urea clearance. Kidney Int 66[Suppl 89]: S3-S24, 2004
19. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity. Report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176-1181, 1981
20. Sargent JA: Control of dialysis by a single-pool model: The National Cooperative Dialysis Study. Kidney Int 23[Suppl 13]: S19-S24, 1983
21. Laird NM, Berkey CS, Lowrie EG: Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int 23[Suppl 13]: S101-S106, 1983
22. Cambi V, Arisi L, Buzio C, Rossi E, Savazzi G, Migone, L: Short dialysis schedules (SDS)-Finally ready to become routine? Proc Eur Dial Transplant Assoc 11: 112-120, 1975
23. Rotellar E, Martinez E, Samsó JM, Barrios J, Simó R, Mulero JF, Perez D, Bandrés S, Piñol J: Why dialyze more than 6 hours a week? Trans Am Soc Artif Intern Organs 31: 538-545, 1985
24. Berger EE, Lowrie EG: Mortality and the length of dialysis. JAMA, 265: 909-910, 1991
25. Barth RH: Short hemodialysis: Big trouble in a small package. In: Death on Hemodialysis: Preventable or Inevitable?, edited by Hingham MA, Friedman E, Norwell, MA, Kluwer Academic Publishers, 1994, pp 143-157
26. Gotch FA, Yarian S, Keen M: A kinetic survey of US hemodialysis prescriptions. Am J Kidney Dis 15: 511-515, 1990
27. Gotch FA, Sargent J: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526-534, 1985
28. Sargent JA, Gotch FA: The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int 7[Suppl 2]: S35-S44, 1975
29. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
30. Greene T, Daugirdas J, Depner T, Allon M, Beck G, Chumela C, Delmez J, Gotch F, Kusek JW, Levin N, Owen W, Schulman G, Starr R, Toto R, Eknoyan G: Association of achieved dialysis dose with mortality in the Hemodialysis Study: An example of dose-targeting bias. J Am Soc Nephrol 16: 3371-3380, 2005
31. Frankenfield DL, McClellan WM, Helgerson SD, Lowrie EG, Rocco MV, Owen WF: Relationship between urea reduction ratio, demographic characteristics, and body weight in the 1996 national ESRD core indicators project. Am J Kidney Dis 33: 584-591, 1999
32. Owen WF, Chertow GM, Lazarus JM, Lowrie EG: Dose of hemodialysis and survival: Differences by race and sex. JAMA 280: 1764-1768, 1998
33. Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG: Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int 56: 1872-1878, 1999
34. Lowrie EG, Li Z, Ofsthun N, Lazarus JM: Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 62: 1891-1897, 2002
35. Lowrie EG, Li Z, Ofsthun N, Lazarus M: Measurement of dialyzer clearance, dialysis time, and body size: Death risk relationships among patients. Kidney Int 66: 2077-2084, 2004
36. Lowrie EG, Li Z, Ofsthun N, Lazarus JM: The online measurement of hemodialysis dose (Kt): Clinical outcome as a function of body surface area. Kidney Int 68: 1344-1354, 2005
37. Lowrie EG: The normalized treatment ratio (Kt/V) is not the best dialysis dose parameter. Blood Purif 18: 286-294, 2000
38. Lowrie EG, Li Z, Ofsthun NJ, Lazarus JM: Evaluating a new method to judge dialysis treatment using online measurements of ionic clearance. Kidney Int 70: 211-217, 2006
39. Eloot S, Torremans A, De Smet R, Marescau B, De Deyn PP, Verdonck P, Vanholder R: Complex compartmental behavior of small water-soluble uremic retention solutes: Evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 50: 279-288, 2007
40. Marshall MR, Byrne BG, Kerr PG, McDonald SP: Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients. Kidney Int 69: 1229-1236, 2006
41. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: Association with reduced mortality in the DOPPS. Kidney lnt 69: 1222-1228, 2006
42. Greene T, Daugirdas JT, Depner TA, Gotch F, Kuhlman M: Targeted solute clearances and fluid removal in the frequent hemodialysis network trials. Am J Kidney Dis 53: 835-844, 2009